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Abstract
Background: Post-operative pancreatic fistula (POPF) formation occurs frequently after a
pancreaticoduodenectomy (PD). Recently, a 10-point Fistula Risk Score (FRS) evaluating the likelihood of
clinically relevant POPF (CR-POPF) development has been described and validated. This scheme has yet
to be evaluated in PD patients managed without intra-operative drain placement.
Methods: Among patients undergoing PD at an academic centre since 2003, a retrospective analysis
calculating FRS and its correlation with CR-POPF development was evaluated by logistic regression.
Secondary analysis examined presentation and management of CR-POPF in undrained PD patients.
Results: FRS was calculated for 265 patients; 97.7% were managed without operative drains. The
overall incidence of CR-POPF was 7.9%. Logistic regression revealed a 1.6-fold increase in CR-POPF risk
per 1-point increase in FRS [95% confidence interval (CI) 1.2–2.0]. The negative predictive value in
patients with FRS <3 was 100%, whereas the positive predictive value of FRS >6 was 16.7%. The median
time to CR-POPF diagnosis was 18 days [interquartile range (IQR) 13–23]; 70.0% required readmission
and 10.0% required a laparotomy.
Conclusions: Among patients without operative drainage, CR-POPF often has delayed presentations
but most are managed non-operatively. The predictive value of high-risk FRS appears limited; conversely,
a low-risk FRS accurately predicts the absence of CR-POPF and seems an appropriate metric for guiding
care.
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Introduction
Outcomes after a pancreaticoduodenectomy (PD) have steadily
improved over the past several decades, in spite of increasing
numbers of resections being performed in populations previously
considered high risk, such as the elderly.1–3However, a persistently
large fraction of patients experience significant morbidity or the
need for readmission after a PD.4Of the PD-specific adverse
events, a post-operative pancreatic fistula (POPF) is both
common and highly morbid. The incidence of POPF has been
variably reported as occurring in 2–22% of PD patients after a
resection,5–7 and has been associated with increased rates of mor-
tality, readmission, hospital costs and prolonged lengths of stay.4,8,9
The standardization of POPF diagnostic criteria by the Inter-
national Study Group of Pancreatic Fistula (ISGPF) in 2005
greatly reduced discrepancies in defining POPF occurrence
between institutions.5 Broadly, POPF were qualitatively defined as
any measurable volume of intraperitoneal fluid collected on or
after post-operative day (POD) three with amylase levels three
times greater than the upper limit of the normal serum value. The
ISGPF characterized clinically insignificant fistulae incidentally
discovered after routine post-operative drainage requiring no
deviation from routine post-operative care as ‘Grade A’ fistulae.
Conversely, POPF necessitating a change in routine management*These authors contributed equally to this work.
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were termed ‘Grade B’, whereas fistulae with life-threatening
sequelae or requiring reoperation were termed ‘Grade C’. Collec-
tively, grade B and C fistulae are referred to as ‘clinically-relevant
POPF’ (CR-POPF).10,11
The ISGPF classification of POPF was first validated in 2007.9
Subsequently, a comprehensive analysis of hypothetical risk
factors for POPF as defined by the ISGPF found that smaller
pancreatic duct size, soft gland texture, increased operative blood
loss and resections performed for ampullary, duodenal, cystic or
islet cell disease were independent risk factors for CR-POPF devel-
opment.12 Recently, a 10-point Fistula Risk Score (FRS) based on
these risk factors has been described by the same group of authors
in an effort to characterize the likelihood that a given patient will
develop a CR-POPF after a PD.13 While soft gland texture and
smaller duct size had been recognized in non-randomized studies
and anecdotally as correlating with CR-POPF formation, this
straightforward scoring system objectively characterized and
attributed relative risk of these factors in relation to POPF devel-
opment. In an ensuing validation study utilizing patients from
three institutions, Miller et al. 14 confirmed the FRS to be predic-
tive of CR-POPF risk. However, as the authors emphasize, PD is
highly variable between surgeons and institutions, both in terms
of its technical implementation and post-operative management
techniques. Accordingly, external validation of the FRS utilizing a
wide variety of PD patients is mandated.
The role of closed suction drains after PD remains controver-
sial; in particular they are of interest in examining POPF devel-
opment and applicability of scoring systems such as the FRS. In
recent years it has been shown that PD can be performed safely
without usage of closed suction drains in many cases,15–17 although
many surgeons continue to have excellent outcomes while
employing one or more drains routinely.18 In the original study
defining the FRS, Callery et al. utilized at least one drain adjacent
to the operative bed. Similarly, over 95% of the cases in the vali-
dation by Miller et al. also utilized operative drains. In our prac-
tice in a high-volume academic center, we have been utilizing
selective intraperitoneal drainage following PD for several years.
As such, this appeared to be an ideal cohort to further evaluate the
FRS advocated by Callery et al. 13 The primary aim of this study
was to evaluate the validity of the FRS in an independent cohort in
which the majority of patients did not receive routine operative
drainage and evaluate the strength of each component of the FRS
in ascribing risk for CR-POPF development. Finally, in a separate
analysis, the clinical presentation and course of patients who
develop CR-POPF after a PD when routine operative drains are
not utilized was analysed, as this population is growing and has
not been widely studied.
Patients and methods
Patient selection and defining adverse events
A prospectively maintained database of consecutive patients who
underwent PD for any indication at Yale-New Haven Hospital by
a single surgeon (R.R.S.) from January 2006 to June 2013 was
retrospectively reviewed. The presence of POPF was assessed and
classified as grade A, B, or C as defined by the ISGPF. For each case,
a corresponding FRS was calculated on a 10-point scale in accord-
ance with the description of gland texture, duct size, etc by Callery
et al. 13 in all patients for which the requisite data were available.
Operative blood loss was determined in concert with the anaes-
thesia and nursing teams. Overall operative morbidity was
graded in accordance with the modified Clavien classification
after 30 days of follow-up, as were mortality and readmission
rates.19,20Clavien grades I and II complications were considered
minor, whereas grade III complications and above were consid-
ered major. Standardized ISGPS definitions were utilized for diag-
nosis of delayed gastric emptying (DGE).21Fluid drained from the
abdomen with positive microbial cultures and amylase content
less than three times normal was considered an intra-abdominal
abscess. Gastro-/duodenojejunostomy or hepaticojejunostomy
leak was defined as radiological or operative identification of
anastomic disruption. Patients who underwent surgery for an
intraductal papillary mucinous neoplasm that were found to have
invasive adenocarcinoma were classified as having adenocarci-
noma for the purposes of analysis.
Operative technique
A pylorus-preserving PD was performed except when precluded
by disease-specific considerations; in all other cases, a classic
(Kausch-Whipple) PD was performed. A pancreaticojejunostomy
was performed in a two-layer end-to-side fashion utilizing duct-
to-mucosa reconstruction whereas a hepaticojejunostomy was
performed in a single-layer end-to-side fashion. A gastro-/
duodenojejunostomy was performed using an end-to-side
(Billroth II) technique. Closed suction drainage was rarely per-
formed and usually only for difficult biliary anastomoses.
Post-operative care
Patients were admitted to the surgical intensive care unit post-
operatively and usually transferred to the surgical ward on post-
operative day (POD) one. After 2008, nasogastric tubes were rarely
employed. A liquid diet was typically initiated on POD 2–3 and
advanced as tolerated. Metoclopramide and octreotide were not
routinely given, but were freely administered when clinically indi-
cated. In patients with operatively placed closed suction drains,
drain amylase was routinely evaluated and drains were discon-
tinued when clinically indicated. After discharge, all patients were
followed for at least 3 months.
Statistical analysis
Summary statistics were used to describe baseline characteristics.
Chi-square tests and Wilcoxon’s rank-sum test were used to
analyse categorical and continuous variables, respectively. Fisher’s
exact test was used to analyse categorical variables with expected
values less than five. Binary logistic regression was used to evaluate
the accuracy of the Fistula Risk Score in the prediction of
CR-POPF. A receiver-operating characteristic (ROC) curve was
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plotted and the area under the curve (AUC) concordance statistic
calculated for model discrimination. The c-statistic varies from
0.5 to 1.0, and the ability of a model to predict outcomes increases
as the c-statistic approaches 1. Positive likelihood ratios (LR+)
were calculated for each score. LR+ represents the probability that
a patient with POPF receives a particular score, divided by the
probability that a patient without POPF receives the same score. A
LR+ greater than 1 indicates that POPF is more likely whereas a
LR+ less than one indicates that POPF is less likely. Statistical
analysis was performed with SPSS version 19 (SPSS, Inc., Chicago,
IL, USA). Data collection and analysis were performed under a
protocol approved by the Yale University School of Medicine
Human Investigations Committee.
Results
Fistula incidence and characteristics
During the study period from 2006 to 2013, 297 patients under-
went PD by a single surgeon of which 265 had sufficient data
available to calculate a FRS (89.2%). Twenty-one patients (7.9%)
had CR-POPF (i.e. met criteria for ISGPF grade B or C fistulae).
All were described as having a soft pancreas texture and only two
underwent PD for pancreatic ductal adenocarcinoma or chronic
pancreatitis. Baseline demographic and operative indication data
are shown in Table 1. The overall median length of stay for all
patients during their index admission was 6 days [range, 3–81;
interquartile range (IQR) 5–7 days]. The most frequent indication
for PD was pancreatic ductal adenocarcinoma. Drains were placed
in only six patients (2.3%); one developed a CR-POPF. Drain
amylase was assessed in the remaining five patients and none were
greater than three times serum amylase. Four operative deaths
were observed (1.5%); none of the deaths were as a result of
POPF-related morbidity (three due to pulmonary complications,
one due to a myocardial infarction).
FRS and adverse events
All 265 patients were stratified as having negligible (0 points), low
(1–2 points), intermediate (3–6 points) or high risk (7–10 points)
by FRS (the same classification utilized by Callery et al.). The
mean FRS (regardless of CR-POPF development) was 3.66
whereas the median FRS was 3. Increasing risk score correlated
with POPF development (P < 0.05), and all patients that devel-
oped fistulae were found to have intermediate or high risk scores
(see Table 2). In addition, the FRS was also found to correlate with
longer lengths of stay regardless of the presence of POPF (P <
0.01). The overall rate of any post-operative adverse event
(Clavien–Dindo score ≠ 0) was 83.2%, with major complications
(Clavien–Dindo score >2) occurring in 15.1% of cases. Aggregate
operative morbidity as measured by Clavien score did not have
any statistically significant association with increased FRS,
although a trend towards a higher incidence of major complica-
tions was observed in patients in the intermediate or high risk FRS
groups. No statistically significant correlation of FRS classification
and additional selected PD-related complications, such as delayed
gastric emptying, intra-abdominal abscess development and
anastomotic leak was observed.
Evaluating the validity of the FRS
Analysis of the predictive value in our cohort of each com-
ponent of the FRS is shown in Table 3. A strong correlation with
fistula development was observed in cases of soft pancreas
texture, decreasing pancreatic duct size and ampullary/duodenal/
cystic/islet cell pathology (P < 0.05 for all). Increased operative
blood loss was not found to correlate with increasing fistula
risk. Rates of CR-POPF and corresponding positive likelihood
ratios at each risk score level are shown in Fig. 1. Binary logistic
regression revealed a 1-point increase in the FRS to be associated
with a 1.6-fold increase in odds of the development of CR-POPF
[95% confidence interval (CI) 1.2–2.0, P = 0.001]. The ROC
(receiver-operating characteristic) curve concordance statistic for
the entire cohort was found to be 0.763 (95% CI 0.684–0.843).
None of the low-risk patients (FRS < 3) developed CR-POPF,
with a corresponding negative predictive value of 100%. Con-
versely, in high-risk patients (FRS >6), the positive predictive
value was 16.7%.
Table 1 Demographic and operative characteristics of patients
undergoing Fistula Risk Score classification
n (%)
Total 265
Age (years)
Mean (SEM) 64.2 (0.7)
Gender
Male 136 (51.3)
Female 129 (48.7)
Technique
PD 125 (47.2)
PPPD 140 (52.8)
Intra-operative placement of drains 6 (2.3)
Post-operative nasogastric tube 79 (29.8)
Indication
Benign 64 (24.2)
Malignant 201 (75.8)
Pathology
Pancreatic carcinoma 103 (38.9)
Cholangiocarcinoma 32 (12.1)
Ampullary adenocarcinoma 30 (11.3)
Duodenal carcinoma 13 (4.9)
Pancreatic cystic neoplasm 42 (15.8)
Neuroendocrine tumour 21 (7.9)
Other 24 (9.1)
PD, pancreaticoduodenectomy; PPPD, pylorus-preserving PD.
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Presentation of CR-POPF in the absence of routine
operative drainage
The clinical presentation and management of all patients during
the study period with CR-POPF who did not have intraperitoneal
drains maintained post-operatively were critically analysed. Of the
21 patients with CR-POPF, one patient did have an intra-operative
drain maintained and was therefore excluded. The results are
shown in Table 4. Fever and abdominal pain were the most
common presenting symptoms (65.0% of patients with either
finding) and leukocytosis was the most common objective finding
Table 2 Correlation of post-operative adverse events and Fistula Risk Score
Negligible risk
(0 points)
n = 17
Low risk
(1–2 points)
n = 72
Intermediate risk
(3–6 points)
n = 152
High risk
(7–10 points)
n = 24
P-value
Median LOS (IQR) 5 (4–6) 5 (4–7) 6 (5–9) 7 (6–9) <0.001
ISGPF classification 0.012
No fistula 17 (100) 72 (100) 135 (88.8) 20 (83.3)
Grade B – – 11 (7.2) 4 (16.7)
Grade C – – 6 (3.9) –
Overall morbidity 0.160
No complications 5 (29.4) 17 (23.6) 19 (12.6) 2 (9.1)
Minor (Clavien ≤2) 10 (58.8) 49 (68.1) 103 (68.2) 17 (77.3)
Major (Clavien ≥3) 2 (11.8) 6 (8.3) 29 (19.2) 3 (13.6)
Specific complications
DGE 1 (5.8) 6 (8.3) 18 (11.8) 2 (8.7) 0.763
Abscess – 2 (2.8) 7 (4.6) 1 (4.2) 0.762
Anastomotic leak – 2 (2.8) 2 (1.3) 1 (4.2) 0.665
Transfusion 1 (5.8) 7 (9.7) 16 (10.5) 1 (4.2) 0.741
Death – 1 (1.4) 3 (2.0) – 0.776
LOS, length of stay; IQR, interquartile range; DGE, delayed gastric emptying.
Table 3 Correlation of Fistula Risk Score components and presence or absence of clinically relevant post-operative pancreatic fistula
(CR-POPF)
Parameter No CR-POPF
n = 244
CR-POPF
n = 21
P-value
Gland texture, n (%) <0.001
Firm 120 (49.2) –
Soft 124 (50.8) 21 (100)
Pathology, n (%) 0.013
Low risk 96 (39.3) 2 (9.5)
High risk 148 (60.7) 19 (90.5)
Duct diameter (cm), n (%) 0.001
≥5 92 (37.7) 2 (9.5)
4 51 (20.9) 5 (23.8)
3 63 (25.8) 4 (19.0)
2 38 (15.6) 10 (47.6)
≤1 – –
Estimated blood loss (ml), n (%) 0.957
≤400 141 (57.8) 13 (61.9)
401–700 62 (25.4) 5 (23.8)
701–1000 22 (9.0) 2 (9.5)
>1000 19 (7.8) 1 (4.8)
‘Low-risk’ pathology is considered resection for pancreatic ductal adenocarcinoma or chronic pancreatitis only. ‘High-risk’ pathology is resection for
any other reason.
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(85.0%). Two patients (10.0%) were diagnosed after a re-
laparotomy with the remainder (n = 18, 90.0%) diagnosed after
observation of an intra-abdominal fluid collection found to be
amylase-rich on subsequent analysis. All patients who were diag-
nosed radiologically were treated with percutaneous drainage.
Nine presented during their index admission (36.0%) with the
remainder requiring readmission for management. Among those
readmitted, the median time to re-presentation was 16 days after
initial discharge (range, 7–42 days).
Discussion
Development of pancreatic fistulae remains one of the most
common and highly morbid adverse events after PD and multiple
interventions have been evaluated that attempt to prevent or miti-
gate the effects of POPF. Trials evaluating these techniques have
thus far shown only a limited ability to impact POPF incidence,
even when broadly applied.22–25The development of the ISGPF
classification for POPF has greatly improved POPF research
through standardization, although alternative schemes are still
occasionally utilized.16 The 10-point FRS developed by Callery
et al. 13 based upon risk factors first described by Pratt et al.12 to
stratify CR-POPF risk13 was recently validated in a multi-
institutional trial.14 As nearly all patients in both the original study
describing the FRS and the study validating it had operative drains
utilized in their care, this study sought to broaden the applicability
of the FRS risk classification by evaluating it in a large cohort of
patients undergoing PD with rare usage of drains. In summary,
the current study found that the FRS was associated with the
development of CR-POPF, and was particularly helpful in ruling
out the possibility of CR-POPF in low-risk patients. However, its
ability to predict the development of CR-POPF in high-risk
patients was limited.
In their original assessment of the FRS, Callery et al. 13 prospec-
tively evaluated the performance of the scheme on a second group
of patients at their institution and described a concordance sta-
tistic (‘c-statistic’) of 0.942 (better = closer to 1.0). In the present
study of undrained patients a c-statistic of 0.763 (95% CI 0.684–
0.843) was found. The moderately decreased concordance
observed compared with the initial FRS study is likely as a result of
the decreased positive predictive value in patients ascribed a high-
risk FRS (16.7% versus 89% in the original study). This is some-
what magnified as the mean FRS in the present study is nearly a
full point higher than the original study (3.66 versus 2.68), in spite
of having a lower overall CR-POPF rate. In their validation of the
FRS scheme in patients with routine drainage after PD, Miller
et al. 14 described a comparable decrease in CR-POPF incidence in
high-risk FRS patients (29%) in spite of a similarly elevated mean
50
45
40
35
30
25
20
Score
0
1
2
3
4
5
6
7
8
9
10
-
-
-
0.6
1.5
1.3
2.8
2.7
-
5.8
-
LR+
Total patients
Total fistulae
T
ot
al
 p
at
ie
nt
s
15
10
5
0
0 1 2 3 4
Fistula risk score (points)
5 6 7 8 9 10
Figure 1 Percentage of patients ascribed to each Fistula Risk Score
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pancreatic fistulae. Likelihood ratio (‘LR+’) for fistula development at
each score shown
Table 4 Presentation of clinically relevant post-operative pancreatic
fistula (POPF) in the absence of post-operative intraperitoneal drain-
age (n = 20)
Clinical findings, n (%)
Leukocytosis 17 (85.0)
Fever 13 (65.0)
Abdominal pain 13 (65.0)
Tachycardia 9 (45.0)
Nausea/vomiting 7 (35.0)
Anorexia 7 (35.0)
Respiratory 5 (25.0)
Fatigue 4 (20.0)
Hypotension 4 (20.0)
Diarrhoea 2 (10.0)
Altered mental status 2 (10.0)
Chest pain 2 (10.0)
Index admission
Post-operative day of diagnosis, median (IQR) 18 (13–23)
Length of stay (days), median (IQR) 7 (6–18.5)
Readmission
POPF requiring readmission, n (%) 14 (70.0)
Length of stay for readmission (days), median (IQR) 10.5 (6–14.0)
Diagnosis, n (%)
Abdominal CT 18 (90.0)
Exploratory laparotomy 2 (10.0)
Treatment, n (%)
CT-guided IR drainage 24 (95.0)
Antibiotics 16 (80.0)
Total parenteral nutrition 5 (20.0)
Reoperation 2 (10.0)
IQR, interquartile range; CT, computed tomography; IR; interventional
radiology.
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FRS (3.54), which resulted in a c-statistic of 0.716 and mirrors the
present study closely. The decreased predictive ability of high-risk
FRS values is likely multifactorial.
Wide variation currently exists in the practice of operative
drainage after pancreatic surgery. This has important effects in
determining the true incidence of POPF in a particular cohort, as
the majority of patients with grade A fistulae may remain undi-
agnosed if intraperitoneal drains are not routinely utilized, result-
ing in a higher POPF incidence (grades A/B/C) in studies where
drain usage is routine. While differences in technical aspects of PD
do not seem to significantly affect the incidence of post-operative
adverse events, such as POPF or DGE development,12,26,27groups
that do not routinely utilize operative drains typically report a
slightly lower incidence of CR-POPF. The overall incidence of
7.9% observed here is comparable to that reported by other
groups where operative drains were not routinely employed.16,17
Callery et al. 13 (in the original FRS study) and Miller et al. 14 (in
the FRS validation) report rates of CR-POPF of 13.0% and 11.4%,
respectively, among their patients (who were routinely drained).
The decreased incidence of CR-POPF observed in the present
cohort may have contributed to the lower positive predictive value
found at higher FRS numbers, as the positive predictive value of a
scoring system depends on the incidence of the event in question.
Operative blood loss is a comparatively large component of the
FRS, as up to 3 of a possible 10 points in the model are attributed
to volume of blood loss. A key finding of the present study was
that a difference in blood loss between patients with and without
CR-POPF was not observed. As a result, among patients who were
granted points for high operative blood loss, the risk for POPF
development appears to be less than that ascribed by the FRS.
Consequently, this would falsely increase the number of predicted
CR-POPFs and also result in the decreased positive predictive
value observed. The prevalence of patients in the present study
with an elevated blood loss (>400 ml, 41.9%) is similar to that
observed in the original FRS and validation studies (36.6% and
36.4%, respectively). The effects of the operative blood loss on
CR-POPF incidence was not reported by Miller et al. 14 in their
FRS validation of drained PD patients. However, during subgroup
analysis, an increased rate of operative blood loss in the current
cohort during cases for PDAC and chronic pancreatitis was
observed, possibly owing to the increased technical difficulty in
these cases and the higher incidence of concomitant vascular
resections during oncological resections. Although this trend did
not reach statistical significance, the protective effect of the larger
duct and firmer gland usually associated with PDAC/chronic pan-
creatitis resections may have mitigated the adverse effects on
CR-POPF formation of increased blood loss endorsed by Callery
et al. 13 In summary, both a lack of correlation of CR-POPF with
blood loss and a lower overall incidence of CR-POPF contributed
to the decreased positive predictive value of the FRS observed in
this study.
Conversely, the negative predictive value in patients with a FRS
less than three (‘negligible’ or ‘low’ risk patients) was excellent
(100%), as none of these patients went on to develop CR-POPF.
The FRS validation of drained PD patients by Miller et al. 14 dem-
onstrates a similarly minimal rate of CR-POPF formation in
patients with a FRS < 3. This is a crucial finding of the present study
and further highlights the utility of the FRS and demonstrates the
potential role for the scheme in clinical practice. Conceivably,
patients categorized as negligible or low risk could be managed
without adjuncts for POPF treatment with confidence. In practices
where selective operative drainage is employed, it could also serve
as a metric for determining which patients can forgo drainage. In
practices that employ fast-track discharge plans or dietary
advancement, confidence in that such steps can be taken in patients
with a low FRS would be increased. Conversely, in those patients
with a higher FRS, interpreting post-operative adverse events in the
context of a higher FRS could direct clinical suspicion and diag-
nostic interventions, leading to earlier POPF diagnosis and treat-
ment.Even although this study demonstrates that not all patients in
intermediate- or high-risk FRS categories develop POPF, increased
awareness of the risk of POPF development would be useful in
patients that do not experience a routine post-operative course.
A secondary objective of this study was to characterize how
patients with CR-POPF present in the absence of routine opera-
tive drainage, as an early diagnosis of POPF is considered one
rationale for the placement of drains. In patients with operative
drains, persistent drain output is commonly considered an indi-
cator of POPF development.28 Among patients without drains, the
presentation of POPF has not been systematically reported. This
study shows that patients typically present within 4 to 6 weeks of
operation, most commonly with leukocytosis, fever and persistent
abdominal pain. Encouragingly, no mortalities secondary to
CR-POPF were observed in spite of a lack of operative drainage,
although two patients became critically ill and required
reoperation. All patients in the cohort ultimately required drain-
age, either via relaparotomy or radiologically-guided percutane-
ous drains. Also, nearly two-thirds did require readmission, with a
median duration of 7 days. Delayed presentation and elevated risk
for readmission seem to be a consistent risk after a PD, as Ahmad
et al. 4 described in a recent multi-centre study evaluating read-
mission after PD.4In general, among those managed without
operative drainage, the incidence of CR-POPF development
appears low and compares favourably with previously published
data. Although those patients who do develop CR-POPF fre-
quently require intervention and readmission, the majority of
these patients are managed with excellent outcomes.
This study was limited in scope by its retrospective nature,
although the data presented here were collected prospectively. In
spite of this, a large cohort with an incidence of CR-POPF and
other post-operative adverse events comparable to published lon-
gitudinal case series was assembled and critically assessed.1,2 With
the multi-institution validation of the FRS performed by Miller
et al. 14 of a large cohort that underwent routine post-operative
drainage combined with the large cohort of undrained patients
presented here, the FRS scheme has been robustly evaluated in a
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sizable group of patients that would be comparable to those at
many centres. Overall, the FRS reliably predicts the absence of
CR-POPF in negligible- and low-risk patients and provides an
objective way to characterize POPF risk, rather than relying on
inference or surgeon experience. The prognostic ability among
patients with an elevated FRS appears somewhat limited. While
further model refinement may yield increased accuracy, the
current FRS classification appears to be appropriate for general
usage and directing fistula-related management decisions.
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